West Coast Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,680
Closed -$352K 3
2025
Q1
$352K Sell
1,680
-100
-6% -$19.4K 0.04% 126
2024
Q4
$316K Sell
1,780
-20
-1% -$3.68K 0.03% 131
2024
Q3
$355K Sell
1,800
-7
-0.4% -$1.31K 0.04% 127
2024
Q2
$310K Buy
1,807
+229
+15% +$37.9K 0.04% 132
2024
Q1
$287K Buy
1,578
+140
+10% +$24.1K 0.03% 135
2023
Q4
$223K Sell
1,438
-38
-3% -$5.54K 0.03% 150
2023
Q3
$220K Sell
1,476
-292
-17% -$42.9K 0.03% 140
2023
Q2
$238K Buy
1,768
+208
+13% +$30.5K 0.03% 140
2023
Q1
$249K Sell
1,560
-1,135
-42% -$174K 0.04% 124
2022
Q4
$436K Buy
2,695
+290
+12% +$44.5K 0.07% 90
2022
Q3
$323K Sell
2,405
-91
-4% -$13.1K 0.06% 93
2022
Q2
$382K Hold
2,496
0.07% 89
2022
Q1
$405K Hold
2,496
0.06% 95
2021
Q4
$338K Buy
2,496
+23
+0.9% +$2.72K 0.05% 108
2021
Q3
$267K Sell
2,473
-1,164
-32% -$133K 0.04% 115
2021
Q2
$410K Hold
3,637
0.07% 100
2021
Q1
$394K Buy
3,637
+718
+25% +$76.8K 0.07% 94
2020
Q4
$313K Sell
2,919
-43
-1% -$4.13K 0.06% 94
2020
Q3
$259K Hold
2,962
0.06% 97
2020
Q2
$291K Buy
+2,962
New +$261K 0.07% 92

Other funds holding ABBV

West Coast Financial's ABBV Position: Q2 2025 in Review

West Coast Financial sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,680 shares — an estimated $352K sold.

West Coast Financial first reported a position in ABBV in Q2 2020 and held it in 20 quarters. The position peaked at $436K in Q4 2022. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • West Coast Financial reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • West Coast Financial sold 1,680 AbbVie shares in Q2 2025, an estimated $352K.
  • West Coast Financial first reported a position in AbbVie in Q2 2020 and held it in 20 quarters.
  • West Coast Financial's AbbVie position peaked at $436K in Q4 2022.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on West Coast Financial's 13F filing for Q2 2025.